OPS
ALNY icon

Orion Portfolio Solutions’s Alnylam Pharmaceuticals ALNY Stock Holding History

Orion Portfolio Solutions’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$1.04M Buy
3,857
+113
+3% +$29K 0.01% 1062
2024
Q4 		$881K Buy
3,744
+203
+6% +$53.4K 0.01% 1122
2024
Q3 		$974K Buy
3,541
+457
+15% +$119K 0.01% 1049
2024
Q2 		$749K Buy
3,084
+939
+44% +$148K 0.01% 1114
2024
Q1 		$321K Sell
2,145
-384
-15% -$64.1K ﹤0.01% 1436
2023
Q4 		$498K Sell
2,529
-56
-2% -$9.54K 0.01% 1212
2023
Q3 		$458K Buy
2,585
+229
+10% +$43.7K 0.01% 1231
2023
Q2 		$447K Sell
2,356
-128
-5% -$25.4K ﹤0.01% 1252
2023
Q1 		$498K Buy
2,484
+1,464
+144% +$308K 0.01% 1143
2022
Q4 		$242K Buy
1,020
+8
+0.8% +$1.71K 0.01% 718
2022
Q3 		$203K Buy
+1,012
New +$193K 0.01% 698
2020
Q3 		– Sell
-75
Closed -$11K – 490
2020
Q2 		$11K Sell
75
-72
-49% -$9.71K ﹤0.01% 1152
2020
Q1 		$16K Buy
147
+72
+96% +$8.31K ﹤0.01% 905
2019
Q4 		$9K Buy
+75
New +$7.48K ﹤0.01% 1024

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Orion Portfolio Solutions's ALNY Position: Q1 2025 in Review

Orion Portfolio Solutions increased its Alnylam Pharmaceuticals (ALNY) stake by 3% in Q1 2025, buying an estimated $29K and bringing the position to 3,857 shares worth $1.04M. The position accounts for 0.01% of the portfolio, ranked #1062.

Orion Portfolio Solutions first reported a position in ALNY in Q4 2019 and has held it in 14 quarters since. 627 funds tracked by Wall St. Rank hold ALNY as of Q1 2025.

  • Orion Portfolio Solutions held 3,857 shares of Alnylam Pharmaceuticals worth $1.04M as of Q1 2025.
  • Orion Portfolio Solutions bought 113 Alnylam Pharmaceuticals shares in Q1 2025, an estimated $29K.
  • Alnylam Pharmaceuticals made up 0.01% of Orion Portfolio Solutions's portfolio in Q1 2025, its #1062 holding.
  • Orion Portfolio Solutions first reported a position in Alnylam Pharmaceuticals in Q4 2019 and has held it in 14 quarters since.
  • 627 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.